The FDA revised its guidance recommending universal testing of the blood supply for Zika virus to protect the 1 million units of blood products that are collected from volunteer donors each month, announced Peter Marks, MD, PhD, the director of the FDA’s Center for Biologics Evaluation and Research.
The implementation of the new recommendations will be staged. Areas with active transmission, such as Puerto Rico and Florida, will begin testing products immediately; within